Arcellx Inc
(ACLX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ACLX | AZN | AMGN | GILD | BMY |
| Company | Arcellx Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 68.85 | 194.02 | 377.04 | 151.47 | 60.94 |
| High | 69.74 | 195.90 | 377.36 | 151.87 | 61.45 |
| Low | 66.12 | 190.60 | 366.88 | 149.30 | 59.95 |
| Latest | 67.29 | 193.58 | 367.95 | 149.17 | 60.52 |
| Change | -1.51 | +5.57 | -7.87 | -2.51 | -0.25 |
| % Change | -2.19% | +2.96% | -2.09% | -1.65% | -0.41% |
| Volume | 236,553 | 1,808,606 | 1,111,749 | 3,779,773 | 5,702,583 |
| 20-Day Average Volume | 837,575 | 4,651,328 | 3,052,681 | 8,017,696 | 13,311,307 |
| Previous Close | 68.80 | 188.01 | 375.82 | 151.68 | 60.77 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 68.57 | 187.37 | 347.73 | 137.39 | 56.48 |
| 20-Day Raw Stochastic | 20.12% | 87.53% | 75.39% | 88.97% | 83.48% |
| 20-Day Relative Strength | 44.47 | 57.68 | 62.25 | 71.15 | 67.70 |
| Weighted Alpha | -3.94 | +37.39 | +33.65 | +51.94 | +24.09 |
| Today's Opinion | 56% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 24% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 40% Sell | 100% Buy | 64% Buy | 40% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.61% since 02/03/26 | +5.03% since 02/03/26 | +8.99% since 02/03/26 | +4.34% since 02/03/26 | +8.31% since 02/03/26 |
| Low | 66.15 on 02/10/26 | 186.32 on 02/04/26 | 342.38 on 02/04/26 | 143.50 on 02/04/26 | 56.43 on 02/04/26 |
| High | 71.25 on 02/05/26 | 195.80 on 02/10/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| 1-Month | |||||
| %Chg | -0.02% since 01/09/26 | +2.27% since 01/09/26 | +13.17% since 01/09/26 | +23.45% since 01/09/26 | +8.57% since 01/09/26 |
| Low | 63.33 on 01/12/26 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 119.63 on 01/12/26 | 53.54 on 01/21/26 |
| High | 76.50 on 01/20/26 | 195.80 on 02/10/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| 3-Month | |||||
| %Chg | -22.67% since 11/10/25 | +10.65% since 11/10/25 | +14.02% since 11/10/25 | +26.53% since 11/10/25 | +28.32% since 11/10/25 |
| Low | 60.35 on 01/05/26 | 174.46 on 11/12/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 93.24 on 11/17/25 | 195.80 on 02/10/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| 6-Month | |||||
| %Chg | -6.01% since 08/08/25 | +31.60% since 08/08/25 | +28.04% since 08/08/25 | +25.20% since 08/08/25 | +31.98% since 08/08/25 |
| Low | 60.35 on 01/05/26 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 94.07 on 10/16/25 | 195.80 on 02/10/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,978,223 | 291,586,208 | 202,371,936 | 188,186,336 | 123,712,712 |
| Shares Outstanding, K | 57,823 | 1,550,908 | 538,481 | 1,240,680 | 2,035,753 |
| Annual Sales | 107,940,000 | 54,073,000,000 | 36,751,000,000 | 28,754,000,000 | 48,194,000,000 |
| Annual Net Income | -107,350,000 | 7,035,000,000 | 7,711,000,000 | 480,000,000 | 7,054,000,000 |
| Last Quarter Sales | 4,950,000 | 15,191,000,000 | 9,866,000,000 | 7,769,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -55,780,000 | 2,533,000,000 | 1,333,000,000 | 3,052,000,000 | 1,087,000,000 |
| 60-Month Beta | 0.36 | 0.34 | 0.46 | 0.36 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.99 on 11/05/25 | 1.19 on 11/06/25 | 5.29 on 02/03/26 | 2.47 on 10/30/25 | 1.26 on 02/05/26 |
| Latest Earnings Date | 02/26/26 | 02/10/26 | 05/07/26 | 02/10/26 | 04/23/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.12 | 17.59 | 18.62 | 10.08 |